20 (AIDX) EBIT Margin (2025 - 2026)
20's (AIDX) quarterly EBIT Margin came in at 408.45% in Q1 2026, down 26902.0% YoY from N/an in Q1 2025, and down 192.95% on a QoQ basis from 139.43% in Q1 2025.
20 (AIDX) EBIT Margin (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of EBIT Margin data on file, last reported at 408.45% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 | -170.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -408.45% |
| Mar 31, 2025 | -139.43% |